Collaboration Programs. The specific Indications to be pursued in the Collaboration will be chosen by Generex in its sole discretion, but with consultation with Amarantus. Non-clinical, clinical, quality, and regulatory Collaboration programs for Indications, including, without limitation, non-clinical and clinical trial protocols, will be designed jointly by Generex and Amarantus.
Appears in 2 contracts
Sources: Intellectual Property Licensing Agreement (Generex Biotechnology Corp), Intellectual Property Licensing Agreement (Amarantus BioSciences, Inc.)